« of 13 »
The role of social networks in recovery from alcohol and drug abuse. American Journal of Drug and Alcohol Abuse. 2014 May;40(3):179-80.
Pubmed Link Return to top.
The Significant Other Checklist: measuring the problems experienced by family members of drug users. Addict Behav. 2005 Jan;30(1):29-47.
Pubmed Link Return to top.
The Survey of Treatment Entry Pressures (STEP): identifying client’s reasons for entering substance abuse treatment. Journal of Clinical Psychology. 2014 Oct;70(10):956-66.
Pubmed Link Return to top.
The use of case vignettes for Addiction Severity Index training. J Subst Abuse Treat. 1997 Sep-Oct;14(5):439-43.
Pubmed Link Return to top.
The validity of the interviewer severity ratings in groups of ASI interviewers with varying training. Addiction. 2001 Sep;96(9):1297-305.
Pubmed Link Return to top.
Training substance abuse clinicians in motivational interviewing using live supervision via teleconferencing. J Consult Clin Psychol. 2012 Jun;80(3):450-64. Epub 2012 Apr 16.
Pubmed Link Return to top.
Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond? J Addict Med. 2015 May-Jun;9(3):238-43.
Pubmed Link Return to top.
Treating the substance-abusing patient in the public sector: “medical necessity” versus “social necessity and social responsibility” in the philadelphia target cities demonstration project. J Subst Abuse Treat. 2000 Jan;18(1):75-7.
Pubmed Link Return to top.
Treatment history: relationship to treatment outcomes. Subst Use Misuse. 2009;44(3):305-21.
Pubmed Link Return to top.
Treatment response of antisocial substance abusers. J Nerv Ment Dis. 1995 Mar;183(3):166-71.
Pubmed Link Return to top.
Treatment services received by supplemental security income drug and alcoholic clients. J Subst Abuse Treat. 2000 Apr;18(3):209-15.
Pubmed Link Return to top.
Use of Psychopathy Checklist with opiate addicts. NIDA Res Monogr. 1990;105:597-8.
Pubmed Link Return to top.
Using the AUDIT-PC to predict alcohol withdrawal in hospitalized patients. J Gen Intern Med. 2014 Jan;29(1):34-40.
Pubmed Link Return to top.
Using web searches to track interest in synthetic marijuana (aka “herbal incense”). Drug and Alcohol Review. 2015 Jan;34(1):105-8.
Pubmed Link Return to top.
Validity of the psychopathy checklist-revised in male methadone patients. Drug Alcohol Depend. 1997 Mar 14;44(2-3):143-9.
Pubmed Link Return to top.
Validity of three measures of antisociality in predicting HIV risk behaviors in methadone-maintenance patients. Drug Alcohol Depend. 1997 Aug 25;47(2):99-107.
Pubmed Link Return to top.
Voluntary intoxication and criminal responsibility. Behav Sci Law. 1999;17(2):195-217.
Return to top.
What can parents do? A review of state laws regarding decision making for adolescent drug abuse and mental health treatment.J Child Adolesc Subst Abuse. 2015;24(3):166-176.
Pubmed Link Return to top.
Young women’s views on testing for sexually transmitted infections and HIV as a risk reduction strategy in mutual and choice-restricted relationships. Appl Nurs Res. 2015 May 28.
Pubmed Link Return to top.
Photo of David R. Gastfriend M.D. David R. Gastfriend M.D. David R. Gastfriend, MD., is a Scientific Advisor at TRI and an addiction psychiatrist who completed his training at Massachusetts General Hospital (MGH). Throughout a 25-year span at Harvard Medical School and MGH he was Director of the MGH Addiction Research Program and founded the MGH/McLean Hospital Addiction Psychiatry Fellowship. His pharmacologic and behavioral research activities included serving as an investigator in the National Institute on Drug Abuse (NIDA) Cocaine Collaborative Study, and as investigator and committee chair in the National Institute on Alcohol Abuse and Alcoholism (NIAAA) COMBINE Study and the NIDA Clinical Trials Network. As the lead researcher on the American Society of Addiction Medicine’s (ASAM’s) Patient Placement Criteria, his efforts to operationalize and validate contributed to its endorsement by most U.S. states, the Veterans Administration and the Department of Defense. Dr. Gastfriend is also the Chief Architect of the ASAM Criteria Software, developed with the support of the U.S. Substance Abuse and Mental Health Services Administration for nationwide release. From 2004 to 2013, Dr. Gastfriend served as Vice President for Scientific Communications at Alkermes, Inc., where he directed scientific publications and presentations on clinical and health economic research in addiction.  Dr. Gastfriend has more than 150 scientific publications including The ASAM Criteria and Addiction Treatment Matching books. He has advised the governments of China, Iceland, Israel, Norway, Russia and the U.S. on advances in alcohol and drug addiction treatment. Dr. Gastfriend has received numerous awards including the NIDA Mid-Career Investigator Award for Patient-Oriented Research in 2000; the “Champion in Health Care – Innovator Award” from the Boston Business Journal for his research on Vivitrol® in 2007; and the ASAM’s McGovern Award and Lecture for contributions to addiction treatment and society.
Return to top.